Abattis Bioceuticals Corp. completed its acquisition of Pro Natura BV from Catalyst Investment Capital Corp. for about €6.7 million.

Netherlands-based Pro Natura is a privately held maker of dietary supplements.

Vancouver, British Columbia-based Abattis is a life sciences and biotechnology company focused on cannabis technologies and biotechnology services for the legal cannabis industry in Canada.